Division of Gastroenterology & Hepatology Research
Our research goals at NYU Langone’s Division of Gastroenterology and Hepatology are to provide access to the latest treatments in the pipeline to our patients and to advance knowledge of gastroenterology and hepatology through innovative basic science, translational research, and clinical trials. We aim to foster a spirit of scientific inquiry and innovation among faculty, fellows, and students.
Our researchers study the biology, prevention, diagnosis, and treatment of gastrointestinal (GI) and liver diseases. Among our current areas of research are the following:
- role of the gut microbiome in health and the pathogenesis of disease such as colorectal cancer, liver cancer, and fatty liver and other diseases
- role of GI infection and gut microbial dysbiosis in the pathogenesis of inflammatory bowel disease
- colorectal cancer prevention, including evaluation of sociodemographic and geographic disparities in colorectal cancer screening and outcomes, the comparative effectiveness of different screening strategies, and novel methods to increase screening adherence
- quality and innovations in enhanced technologies for colon cancer screening
- bariatric endoscopy outcomes in obesity and fatty liver disease
- clinical trials in all areas of liver disease, inflammatory bowel disease, colorectal cancer screening and prevention, and other GI conditions
- cirrhosis and hepatitis C infection
Select Faculty Publications
Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn's Disease
Clinical gastroenterology & hepatology. 2024 Apr ; 22:847-857.e12
Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections: A Nationwide Study
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2024 Apr ; 22:831-846
Physician perceptions on the current and future impact of artificial intelligence to the field of gastroenterology
Gastrointestinal endoscopy. 2024 Apr ; 99:483-489.e2
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses
JHEP reports : innovation in hepatology. 2024 Apr ; 6:100999
Somatic Mutational Analysis in EUS-Guided Biopsy of Pancreatic Adenocarcinoma: Assessing Yield and Impact
The American journal of gastroenterology. 2024 Mar 28;
Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C . difficile Infection
The American journal of gastroenterology. 2024 Mar 19;
Up-to-Date Colonoscopy Use in Asian and Hispanic Subgroups in New York City, 2003-2016
Journal of clinical gastroenterology. 2024 Mar 01; 58:259-270
Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease
Digestive diseases & sciences. 2024 Mar ; 69:743-748